<DOC>
	<DOCNO>NCT01232738</DOCNO>
	<brief_summary>ALS disorder weaken motor strength lung function . Rapid loss motor neuron brain spinal cord ALS patient cause symptom increase weakness loss muscle function . While drug help relieve symptoms ALS , cure ALS . Rasagiline drug possible neuroprotective characteristic . Neuroprotective mean nervous system may protect weakening . It known rasagiline possible neuroprotective characteristic approve use patient another disorder , effectiveness rasagiline patient ALS test .</brief_summary>
	<brief_title>Trial Safety Efficacy Rasagiline Patients With Amyotrophic Lateral Sclerosis ( ALS )</brief_title>
	<detailed_description>The specific aim screen study determine whether rasagiline safe patient population drug potential slow ALS disease progression</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Rasagiline</mesh_term>
	<criteria>1 . A clinical diagnosis laboratorysupported probable , probable , definite ALS , accord modify El Escorial criterion , study investigator ( Appendix IV ) . 2 . 21 80 year age inclusive . 3 . VC great equal 75 % predict screening baseline . 4 . Onset weakness within 3 year prior enrollment . 5 . If patient take riluzole ALS , must stable dose least thirty day prior baseline visit . 6 . Women childbearing age must nonlactating surgically sterile use effective method birth control negative pregnancy test . 7 . Willing able give sign informed consent approve Institutional Review Board ( IRB ) . Exclusion criteria 1 . Requirement tracheotomy ventilation noninvasive ventilation &gt; 23 hour per day . 2 . Patients sympathomimetic agent . This include pseudoephedrine , phenylephrine , phenylpropanolamine , ephedrine . 3 . Patients analgesic serotoninergic property meperidine , tramadol , methadone propoxyphen , flexeril . 4 . Patients fluoxetine fluvoxamine . 5 . Patients take amitriptyline &gt; 50 mg/d , trazodone sertraline &gt; 100 mg/d , citalogram &gt; 20 mg/d paroxetine &gt; 30 mg/d . 6 . Diagnosis neurodegenerative disease ( Parkinson disease , Alzheimer disease , etc ) . 7 . Clinically significant history unstable medical illness ( unstable angina , advanced cancer , etc ) last 30 day . 8 . History renal disease . 9 . History liver disease . 10 . Current pregnancy lactation . 11 . Limited mental capacity patient provide write informed consent comply evaluation procedure . 12 . History recent alcohol drug abuse noncompliance treatment experimental protocol . 13 . VC &lt; 75 % predict . 14 . Receipt investigational drug within past 30 day . 15 . Women potential become pregnant practice effective birth control .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>